Assuming you were one of the many, many people who went out to see “The Devil Wears Prada 2” this weekend — or you just love high fashion in general — you might be really looking forward to this ...

With the recent launches of Novo Nordisk’s Wegovy pill and Eli Lilly’s Foundayo, the obesity market has started to shift toward oral GLP-1 drugs. While Novo leverages its first-mover advantage with ...